Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0386 2019/20 Use of Risankizumab

Freedom of Information Request: 0386 2019/20

Recently NICE approved the use of risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults.

Do you have any patients on this treatment? If yes, how many?

Yes, 3 patients

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.